subject area of
- Adjuvant therapy for cancer of the colon. Academic Article
- Antiemetic Effectiveness and Nausea and Vomiting Incidence During Capecitabine and Oxaliplatin Chemotherapy Academic Article
- Biomarkers of 5-fu response in colon cancer [Brief Commentary] Comment
- Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: A pilot study Academic Article
- Customizing chemotherapy for colon cancer: the potential of gene expression profiling Academic Article
- Effect of immunosuppressive agents on hepatocyte apoptosis post-liver transplantation Academic Article
- Gene Expression Profiling-Based Prediction of Response of Colon Carcinoma Cells to 5-Fluorouracil and Camptothecin Academic Article
- Management of Colorectal Cancer in Elderly Patients Academic Article
- Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver Academic Article
- Oral versus intravenous fluoropyrimidines for colorectal cancer Academic Article
- Rapid Selection against Truncation Mutants in Yeast Reverse Two-Hybrid Screens Academic Article
- Survival Associated with 5-Fluorouracil–Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer Academic Article
- Symptomatic 5-fluorouracil-induced sinus bradycardia Academic Article
- Targeted chemoradiation in metastatic colorectal cancer: A phase i trial of 131i-hua33 with concurrent capecitabine Academic Article
- Use of Adjuvant Chemotherapy and Radiation Therapy for Rectal Cancer Among the Elderly: A Population-Based Study Academic Article
- Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study Academic Article
- Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer Academic Article